Related Experiment Video
Updated: Jun 27, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Probiotic-associated Bacillus subtilis subsp. subtilis catheter-related bloodstream infection in a preterm infant: a
Jiajia Chen1, Xuelan Liu2, Xiang Huang2
1Department of Clinical Pharmacy, Jieyang People's Hospital, Jieyang, Guangdong, China.
Insights
A preterm infant developed catheter-related bloodstream infection (CRBSI) during Bacillus subtilis probiotic therapy. This case highlights the potential infectious risks of probiotics in neonates with central venous catheters.
Area of Science:
- Neonatal Medicine
- Microbiology
- Infectious Diseases
Background:
- Probiotics are increasingly used in neonatal care.
- Bacillus subtilis is a commonly used probiotic strain.
- Catheter-related bloodstream infections (CRBSI) are a significant concern in neonates.
Purpose of the Study:
- To report a case of CRBSI potentially linked to Bacillus subtilis probiotic administration.
- To raise awareness of potential infectious risks associated with probiotics in vulnerable neonates.
Main Methods:
- Case report of a preterm infant receiving oral Bacillus subtilis probiotic.
- Diagnosis of CRBSI confirmed by differential time to positivity in blood cultures.
- Antimicrobial susceptibility profiling of clinical isolates and the probiotic strain.
Main Results:
- The preterm infant developed systemic inflammation during probiotic therapy.
- CRBSI was diagnosed.
- Clinical isolates and the probiotic strain exhibited identical antimicrobial susceptibility profiles, suggesting a potential link.
Conclusions:
- Bacillus subtilis probiotic administration may pose an infectious risk in neonates, especially those with central venous access.
- Probiotics should be considered a potential source of sepsis in neonates with CRBSI.
- Further investigation into the safety of probiotics in neonatal populations is warranted.
Abstract:
We report the case of catheter-related bloodstream infection (CRBSI) potentially associated with probiotic administration of Bacillus subtilis subsp. subtilis. A 32⁺⁵-week preterm infant developed systemic inflammation during oral probiotic therapy. CRBSI was definitively diagnosed via differential time to positivity between peripheral and catheter-drawn blood cultures. Microbiological analysis demonstrated that clinical isolates and the probiotic strain shared identical antimicrobial susceptibility profiles; however, this is not definitive proof of strain identity. This novel case suggests a potential infectious risk for B. subtilis in neonates with central venous access and underscores the necessity of considering probiotics as a potential source of catheter-related sepsis.
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microbiota Modulation by Antibiotics
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Probiotics

